These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 779631
1. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B. Beggs WH, Sarosi GA, Steele NM. Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631 [Abstract] [Full Text] [Related]
2. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. Hoeprich PD, Huston AC. J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147 [Abstract] [Full Text] [Related]
3. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone. Beggs WH, Andrews FA, Sarosi GA. Chemotherapy; 1981 Aug; 27(4):247-51. PubMed ID: 7195793 [Abstract] [Full Text] [Related]
4. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans. Beggs WH, Sarosi GA. Chemotherapy; 1982 Aug; 28(5):341-4. PubMed ID: 6754278 [Abstract] [Full Text] [Related]
5. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans. Chen HH, Liushih RN, Hsieh WC. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097 [Abstract] [Full Text] [Related]
6. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod]. Guinet R. Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739 [Abstract] [Full Text] [Related]
7. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans]. Rumler W, Heins S. Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290 [No Abstract] [Full Text] [Related]
8. In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA. Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814 [Abstract] [Full Text] [Related]
12. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates. Nobre G, Sobral T, Ferreira AF. Mycopathologia; 1981 Jan 30; 73(1):39-41. PubMed ID: 7012631 [Abstract] [Full Text] [Related]
13. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system. Ellis NS, Bartlett MS, Smith JW. Am J Clin Pathol; 1979 Aug 30; 72(2):194-8. PubMed ID: 382827 [Abstract] [Full Text] [Related]
14. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles. Vakil R, Knilans K, Andes D, Kwon GS. Pharm Res; 2008 Sep 30; 25(9):2056-64. PubMed ID: 18415047 [Abstract] [Full Text] [Related]
15. [Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro]. Macura AB, Dwernicka B. Med Dosw Mikrobiol; 1989 Sep 30; 41(1):67-70. PubMed ID: 2668662 [Abstract] [Full Text] [Related]
16. Interaction between Candida agglutinins and antifungal agents. Lutz JC, Nugent KM. Mycopathologia; 1987 Jul 30; 99(1):21-4. PubMed ID: 3306393 [Abstract] [Full Text] [Related]
17. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts. Hamilton-Miller JM. Sabouraudia; 1972 Nov 30; 10(3):276-83. PubMed ID: 4565443 [No Abstract] [Full Text] [Related]
20. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona]. Torres-Rodríguez JM, Sabaté M, Gallach C, Carrillo A, Madrenys N. Enferm Infecc Microbiol Clin; 1990 Feb 30; 8(2):91-3. PubMed ID: 2098147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]